EX-527, a synthetic SIRT1 inhibitor, has been extensively studied for its ability to suppress tumor cell proliferation by modulating SIRT1-mediated pathways, thereby enhancing apoptosis and decreasing cell viability (Ceballos et al., 2021). Here, SIRT1 is linked to neoplasm.